Eltrombopag: all 135 studies that test it
Page 1 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITPNot yet recruitingNCT07687134Phase 2
- A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.Not yet recruitingNCT07660172Phase 2
- Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITPNot yet recruitingNCT07189910Phase 4
- Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous DiseaseEnrolling by invitationNCT07113743Phase 1/2
- Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic PurpuraRecruitingNCT07093606Not applicable
- Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid FailureNot yet recruitingNCT06790888Not applicable
- REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2Not yet recruitingNCT06607367Phase 1/2
- Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.RecruitingNCT06531018Phase 1/2
- Outcomes in Bone Marrow Aplasia.Not yet recruitingNCT06493981Phase 3
- Eltrombopag for Peripheral Blood Stem Cell HarvestRecruitingNCT05961410Phase 2
- Immune Thrombocytopenia Management in AdultsRecruitingNCT05861297Phase 4
- Eltrombopag for Chemotherapy-induced ThrombocytopeniaRecruitingNCT04600960Phase 2
- Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)RecruitingNCT04304820Phase 2Results posted
- Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic DiseaseRecruitingNCT03844360Phase 4
- A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITPCompletedNCT04346654Phase 2Results posted
- Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic AnemiaCompletedNCT04328727Phase 2Results posted
- Treatment of Refractory Diamond-Blackfan Anemia With EltrombopagCompletedNCT04269889Phase 1/2Results posted
- Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects.CompletedNCT03988608Phase 2Results posted
- Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in ChildrenCompletedNCT03939637Phase 3Results posted
- Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft FunctionTerminatedNCT03718533Phase 2Results posted
- A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITPCompletedNCT03524612Phase 2Results posted
- Eltrombopag for Fanconi AnemiaActive, not recruitingNCT03206086Phase 2Results posted
- A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic AnemiaCompletedNCT03025698Phase 2Results posted
- Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic AnemiaCompletedNCT02998645Phase 2Results posted
- Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) SubjectsCompletedNCT02404025Phase 2Results posted
- A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT02201290Phase 3Results posted
- A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)TerminatedNCT02158936Phase 3Results posted
- A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic AnemiaCompletedNCT02148133Phase 2Results posted
- Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing ChemotherapyCompletedNCT02071901Phase 2Results posted
- Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)TerminatedNCT02010645Phase 2Results posted
- A Rollover Study to Provide Continued Treatment With EltrombopagCompletedNCT01957176Phase 4Results posted
- Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing TransplantCompletedNCT01927731Phase 2Results posted
- Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)CompletedNCT01893372Phase 2Results posted
- Extended Dosing With Eltrombopag for Severe Aplastic AnemiaCompletedNCT01891994Phase 2Results posted
- A Safety and Efficacy Study of Eltrombopag in Subjects With AMLCompletedNCT01890746Phase 2Results posted
- Safety and Efficacy of Eltrombopag at Escalated DosesCompletedNCT01880047Phase 2Results posted
- Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis CTerminatedNCT01821625Phase 2/3Results posted
- Eltrombopag Phase III Study In Chinese Chronic ITP PatientsCompletedNCT01762761Phase 3Results posted
- Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic AnemiaCompletedNCT01703169Phase 2Results posted
- Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected PatientsCompletedNCT01636778Phase 2Results posted
- Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.CompletedNCT01520909Phase 3Results posted
- Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple MyelomaTerminatedNCT01484314Phase 2Results posted
- A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid LeukemiaCompletedNCT01440374Phase 2Results posted
- Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase TherapyCompletedNCT01428635Phase 2/3Results posted
- Eltrombopag for Moderate Aplastic AnemiaCompletedNCT01328587Phase 2Results posted
- Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)CompletedNCT01168921Phase 2Results posted
- Safety and Efficacy Study for Solid Tumor Patients Treated With EltrombopagCompletedNCT01147809Phase 2Results posted
- Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related DiseaseCompletedNCT01133860Phase 2Results posted
- Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)TerminatedNCT01113502Phase 1/2Results posted
- A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT01098487Phase 4Results posted
- Eltrombopag for Post Transplant ThrombocytopeniaCompletedNCT01000051Phase 2Results posted
- Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390CompletedNCT00996216Phase 3Results posted
- A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)CompletedNCT00961064Phase 2Results posted
- A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia PatientsCompletedNCT00922883Phase 2Results posted
- Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) PatientsTerminatedNCT00909363Phase 2Results posted
- Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00908037Phase 2Results posted
- Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body IrradiationCompletedNCT00903929Phase 1Results posted
- Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00902018Phase 2Results posted
- Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver DiseaseCompletedNCT00861601Phase 2Results posted
- Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00828750Phase 3Results posted
- Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
- Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00540423Phase 3Results posted
- Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver DiseaseCompletedNCT00529568Phase 3Results posted
- Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver DiseaseCompletedNCT00516321Phase 3Results posted
- Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)CompletedNCT00424177Phase 2Results posted
- RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With EltrombopagCompletedNCT00370331Phase 3Results posted
- EXTEND (Eltrombopag Extended Dosing Study)CompletedNCT00351468Phase 3Results posted
- Bioequivalence Study of Revolade® Eltrombopag 50 mgActive, not recruitingNCT06834451Phase 4
- Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 MutationsSuspendedNCT06630221Phase 2
- Eltrombopag for Treatment of Fanconi AnemiaCompletedNCT06045052Phase 2
- A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on AdagrasibCompletedNCT05924152Phase 1
- The Use of Eltrombopag Post HSCT in BMFDCompletedNCT05466201Phase 2/3
- Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CARTStatus unknownNCT05286164Phase 2
- Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITPCompletedNCT04917679Phase 2
- Immunomodulation With Eltrombopag in ITPCompletedNCT04812483Phase 2
- Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion DependenceActive, not recruitingNCT04797000Phase 2
- Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)CompletedNCT04542382Phase 1
- Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Status unknownNCT04518878Phase 1
- Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid TumorsTerminatedNCT04485416Phase 1
- Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich SyndromeStatus unknownNCT04371939Phase 2
- Eltrombopag in Chronic ITPStatus unknownNCT04102033Phase 4
- RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantationTerminatedNCT03948529Phase 2
- Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic PurpuraCompletedNCT03830749Phase 2
- A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITPCompletedNCT03754634Phase 2
- Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AMLStatus unknownNCT03701217Phase 2/3
- to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV InfectionCompletedNCT03664518Phase 2
- Perioperative Eltrombopag in Patients With Inherited ThrombocytopeniaCompletedNCT03638817Phase 2
- Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction ChemotherapyActive, not recruitingNCT03603795Phase 2
- Eltrombopag vs. rhTPO to Increase Platelet Level After HSCTCompletedNCT03515096Phase 3
- Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT03437603Phase 2
- Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AAStatus unknownNCT03413306Phase 3
- The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.CompletedNCT03412188Not applicable
- Eltrombopag & Cyclosporine in Children With Sever Aplastic AnemiaCompletedNCT03243656Phase 4
- Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5qTerminatedNCT02928419Phase 2
- Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic SyndromesActive, not recruitingNCT02912208Phase 2
- Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP PatientsStatus unknownNCT02877212Phase 3
- Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune ThrombocytopeniaStatus unknownNCT02834286Phase 2
- Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)CompletedNCT02773225Phase 2/3
- A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML PatientsTerminatedNCT02446145Phase 2
- Eltrombopag for Inherited ThrombocytopeniasCompletedNCT02422394Phase 2